Target intelligence / Profile preview

Molybdate-binding periplasmic protein (ModA) (ModA)

Target
ModA
Molecular classification
Transporter, Periplasmic binding protein, ABC transporter component
01

Overview

ModA is the periplasmic binding protein component of the high-affinity molybdate ABC transporter system (ModABC) in Acinetobacter baumannii. It is responsible for scavenging trace amounts of molybdate from the environment and delivering it to the membrane-bound transport complex, which is essential for the biosynthesis of the molybdenum cofactor (MoCo). This cofactor is required for the function of various molybdoenzymes, such as nitrate reductase and xanthine dehydrogenase, which play critical roles in bacterial metabolism and survival, particularly under the anaerobic or low-oxygen conditions often encountered during host infection. As A. baumannii is a prominent multi-drug resistant (MDR) pathogen associated with severe hospital-acquired infections like pneumonia and sepsis, ModA has emerged as a potential therapeutic target for novel antibacterial strategies. By targeting the nutrient acquisition systems of the bacteria, researchers aim to starve the pathogen of essential trace elements, thereby attenuating its growth and virulence. While no drugs are currently approved specifically for this target, ModA is a subject of interest in structural genomics and anti-virulence drug discovery efforts aimed at overcoming antibiotic resistance.

Other names
Molybdate-binding proteinPeriplasmic molybdate-binding proteinModA subunit of the molybdate ABC transporterMolybdate-binding protein ModA
02

Mechanism of action

Inhibition of molybdate uptake, leading to the depletion of essential molybdenum cofactors required for the activity of bacterial molybdoenzymes, thereby impairing metabolic function and reducing virulence.

03

Biological functions

Molybdate transportIon homeostasisNutrient acquisitionAnaerobic respiration
04

Disease associations

Infection
05

Safety considerations

Bacterial resistance through alternative low-affinity uptake pathwaysPotential for off-target effects if human molybdenum transport mechanisms are inadvertently affected (though human transport is distinct)
06

Biomarkers

Bacterial molybdenum levelsModA expression levels

Beyond the preview

Go deeper on Molybdate-binding periplasmic protein (ModA) (ModA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molybdate-binding periplasmic protein (ModA) (ModA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call